Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the first Phase III (FENhance 2) of ...

Strava, the app for active people with more than 180 million users, today announced the launch of its new "For a Cause" activity tag, enabling people to use their movement to inspire action and raise ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today reported financial results for ...

Medical experts are using board game therapy for the mental and emotional well-being of individuals across all age groups ...

More than 1,500 riders took to Highway 101 on Nov. 1 for the annual Bike the Coast event, cycling throughout San Diego County ...

It was just five days after Chelsea Shields had the wedding of her dreams that things went wrong. ‘I woke up unable to see ...

I have spent my career caring for patients with chronic pain, dementia and other conditions that drain not only quality of ...

As of November 12, 2025, ProMIS has fully enrolled Cohorts 1 and 2 and is well into Cohort 3, with complete enrollment expected before the end of the year. PMN310 continues to demonstrate a favorable ...

Watch Patient calls for MS medication coverage Video Online, on GlobalNews.ca ...

Collaboration Revenues: Voyager had collaboration revenue of $13.4 million for the third quarter of 2025, compared to $24.6 million for the same period in 2024. The decrease was primarily due to ...

Cohorts 1 and 2 are fully enrolledPMN310 continues to demonstrate a favorable safety profileOn track to report 6-month interim data in Q2 2026 ...